MGTX
Price
$6.61
Change
-$0.06 (-0.90%)
Updated
Jun 27 closing price
Capitalization
533.63M
39 days until earnings call
TPST
Price
$6.90
Change
-$0.19 (-2.68%)
Updated
Jun 27 closing price
Capitalization
25.41M
39 days until earnings call
Interact to see
Advertisement

MGTX vs TPST

Header iconMGTX vs TPST Comparison
Open Charts MGTX vs TPSTBanner chart's image
MeiraGTx Holdings
Price$6.61
Change-$0.06 (-0.90%)
Volume$942.17K
Capitalization533.63M
Tempest Therapeutics
Price$6.90
Change-$0.19 (-2.68%)
Volume$79.88K
Capitalization25.41M
MGTX vs TPST Comparison Chart in %
Loading...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MGTX vs. TPST commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGTX is a Buy and TPST is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (MGTX: $6.61 vs. TPST: $6.90)
Brand notoriety: MGTX and TPST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGTX: 182% vs. TPST: 61%
Market capitalization -- MGTX: $533.63M vs. TPST: $25.41M
MGTX [@Biotechnology] is valued at $533.63M. TPST’s [@Biotechnology] market capitalization is $25.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGTX’s FA Score shows that 0 FA rating(s) are green whileTPST’s FA Score has 0 green FA rating(s).

  • MGTX’s FA Score: 0 green, 5 red.
  • TPST’s FA Score: 0 green, 5 red.
According to our system of comparison, TPST is a better buy in the long-term than MGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGTX’s TA Score shows that 6 TA indicator(s) are bullish while TPST’s TA Score has 1 bullish TA indicator(s).

  • MGTX’s TA Score: 6 bullish, 5 bearish.
  • TPST’s TA Score: 1 bullish, 8 bearish.
According to our system of comparison, MGTX is a better buy in the short-term than TPST.

Price Growth

MGTX (@Biotechnology) experienced а +4.26% price change this week, while TPST (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

MGTX is expected to report earnings on Aug 07, 2025.

TPST is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGTX($534M) has a higher market cap than TPST($25.4M). MGTX YTD gains are higher at: 8.539 vs. TPST (-36.397). TPST has higher annual earnings (EBITDA): -43.32M vs. MGTX (-141.78M). MGTX has more cash in the bank: 66.5M vs. TPST (21.5M). TPST has less debt than MGTX: TPST (13.1M) vs MGTX (80.9M). MGTX has higher revenues than TPST: MGTX (34.5M) vs TPST (0).
MGTXTPSTMGTX / TPST
Capitalization534M25.4M2,102%
EBITDA-141.78M-43.32M327%
Gain YTD8.539-36.397-23%
P/E RatioN/AN/A-
Revenue34.5M0-
Total Cash66.5M21.5M309%
Total Debt80.9M13.1M618%
FUNDAMENTALS RATINGS
MGTX vs TPST: Fundamental Ratings
MGTX
TPST
OUTLOOK RATING
1..100
8244
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
48
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
4165
P/E GROWTH RATING
1..100
10090
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TPST's Valuation (48) in the Pharmaceuticals Major industry is in the same range as MGTX (74) in the Biotechnology industry. This means that TPST’s stock grew similarly to MGTX’s over the last 12 months.

TPST's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as MGTX (100) in the Biotechnology industry. This means that TPST’s stock grew similarly to MGTX’s over the last 12 months.

MGTX's SMR Rating (99) in the Biotechnology industry is in the same range as TPST (100) in the Pharmaceuticals Major industry. This means that MGTX’s stock grew similarly to TPST’s over the last 12 months.

MGTX's Price Growth Rating (41) in the Biotechnology industry is in the same range as TPST (65) in the Pharmaceuticals Major industry. This means that MGTX’s stock grew similarly to TPST’s over the last 12 months.

TPST's P/E Growth Rating (90) in the Pharmaceuticals Major industry is in the same range as MGTX (100) in the Biotechnology industry. This means that TPST’s stock grew similarly to MGTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MGTXTPST
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 13 days ago
84%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PSA289.881.31
+0.45%
Public Storage
DNB9.08N/A
N/A
Dun & Bradstreet Holdings
CRDF3.15-0.01
-0.32%
Cardiff Oncology
TXMD1.12-0.05
-4.27%
TherapeuticsMD
HUT17.66-1.02
-5.46%
Hut 8 Corp

MGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with AURA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
-0.90%
AURA - MGTX
53%
Loosely correlated
-0.16%
KRRO - MGTX
50%
Loosely correlated
-3.16%
IDYA - MGTX
49%
Loosely correlated
-4.13%
RGNX - MGTX
48%
Loosely correlated
-4.11%
TRDA - MGTX
48%
Loosely correlated
-1.57%
More

TPST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TPST has been loosely correlated with PHIO. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TPST jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TPST
1D Price
Change %
TPST100%
-2.68%
PHIO - TPST
51%
Loosely correlated
-1.81%
ABCZF - TPST
49%
Loosely correlated
N/A
RXRX - TPST
38%
Loosely correlated
-6.85%
MGTX - TPST
37%
Loosely correlated
-0.90%
IMNM - TPST
37%
Loosely correlated
-0.23%
More